NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
SWSCX
Price
$25.49
Change
-$0.10 (-0.39%)
Updated
Jul 31 closing price
Net Assets
657.17M
Interact to see
Advertisement

NAESX vs SWSCX

NAESX vs SWSCX Comparison Chart in %
View a ticker or compare two or three
VS
NAESX vs. SWSCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAESX is a Hold and SWSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. SWSCX (657M). NAESX pays higher dividends than SWSCX: NAESX (1.10) vs SWSCX (0.12). NAESX was incepted earlier than SWSCX: NAESX (66 years) vs SWSCX (23 years). SWSCX (1.09) is less costly to investors than NAESX (0.17). SWSCX is a more actively managed with annual turnover of: 108.00 vs. NAESX (17.00). NAESX (0) and SWSCX (0) have matching initial minimum investment requirements. SWSCX annual gain was more profitable for investors over the last year : 32.12 vs. NAESX (22.56). NAESX return over 5 years is better than : 34.95 vs. SWSCX (13.59).
NAESXSWSCXNAESX / SWSCX
Total Expense Ratio0.171.0916%
Annual Report Gross Expense Ratio0.171.0916%
Fund Existence66 years23 years-
Gain YTD14.56324.16060%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets189B657M28,767%
Annual Yield % from dividends1.100.12952%
Returns for 1 year22.5632.1270%
Returns for 3 years43.3033.35130%
Returns for 5 years34.9513.59257%
Returns for 10 years155.2835.26440%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv